Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485250 · ClinicalTrials.gov registry record
A Cross-Cultural Assessment of the Motivations of Healthy Participants in Phase I Research
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,278
- Enrollment target
NCT01485250: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT01485250 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,278 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01485250 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,278 participants
- Enrollment target
Study Summary
Background: * Individuals often participate in clinical trials to seek new therapies and free medical treatments for their illnesses or chronic conditions. However, less is known about the motivations of the healthy individuals who volunteer for research studies. * Although many healthy volunteers participate in clinical trials for financial compensation, the particular risks involved in testing drugs that have not been tried in human clinical trials pose potential dangers for healthy volunteers in Phase I studies. More research is needed to understand the motivations of volunteers who participate in Phase I clinical trials. Objectives: \- To evaluate the primary and secondary motivations of healthy participants in research studies. Eligibility: \- Individuals at least 18 years of age who are healthy volunteers in selected Pfizer Phase I clinical trials. Design: * Individuals who express interest in participating in specific Pfizer Phase I drug studies will be asked to complete a short questionnaire after completing the standard consent session for the study. * Those who enroll in the trial will be asked to complete a second questionnaire prior to discharge from the study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,278 participants |
| Start Date | 2010-02-19 |
| Est. Completion | 2018-08-08 |
What the finished NCT01485250 record still lists
NCT01485250 is an observational study that tracks outcomes without assigning an intervention. Its 1,278 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01485250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01485250 about?
NCT01485250 is a clinical study titled "A Cross-Cultural Assessment of the Motivations of Healthy Participants in Phase I Research". Background: * Individuals often participate in clinical trials to seek new therapies and free medical treatments for their illnesses or chronic conditions. However, less is known about the motivations of the healthy individuals who volunteer for research studies. * Although many healthy volunteers ...
What is the current status of trial NCT01485250?
This trial is currently completed. The enrollment target is 1,278 participants. The study started on 2010-02-19. Estimated completion is 2018-08-08.
Who is sponsoring clinical trial NCT01485250?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI